Newamsterdam Pharma Company N.V. (NAMS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NAMS | INDV | CORT | ||
| Company | Newamsterdam Pharma Company N.V. | Indivior Pharmaceuticals Inc | Corcept Therapeutics | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 34.60 | 34.25 | 33.05 | ||
| High | 34.60 | 34.25 | 33.05 | ||
| Low | 34.60 | 34.25 | 33.05 | ||
| Latest | 34.35 | 34.61 | 33.68 | ||
| Change | -0.28 | +0.17 | -0.56 | ||
| % Change | -0.81% | +0.49% | -1.64% | ||
| Volume | 30,789 | 1,083 | 7,976 | ||
| 20-Day Average Volume | 586,054 | 1,576,539 | 2,079,099 | ||
| Previous Close | 34.63 | 34.44 | 34.24 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 33.53 | 34.37 | 40.75 | ||
| 20-Day Raw Stochastic | 56.47% | 44.58% | 23.86% | ||
| 20-Day Relative Strength | 51.77 | 50.37 | 31.99 | ||
| Weighted Alpha | +95.03 | +239.67 | -34.48 | ||
| Today's Opinion | 40% Buy | 40% Buy | 100% Sell | ||
| Previous Opinion | 40% Buy | 56% Buy | 100% Sell | ||
| Last Month's Opinion | 40% Buy | 56% Buy | 88% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.75% since 02/12/26 | +1.45% since 02/12/26 | -13.80% since 02/12/26 | ||
| Low | 33.51 on 02/19/26 | 33.70 on 02/13/26 | 28.66 on 02/19/26 | ||
| High | 37.76 on 02/18/26 | 35.57 on 02/18/26 | 40.51 on 02/18/26 | ||
| 1-Month | |||||
| %Chg | +6.76% since 01/20/26 | +3.95% since 01/20/26 | -6.35% since 01/20/26 | ||
| Low | 30.50 on 01/30/26 | 32.65 on 01/21/26 | 28.66 on 02/19/26 | ||
| High | 37.76 on 02/18/26 | 36.03 on 02/02/26 | 47.06 on 01/28/26 | ||
| 3-Month | |||||
| %Chg | -8.25% since 11/20/25 | +7.81% since 11/20/25 | -55.96% since 11/20/25 | ||
| Low | 30.17 on 01/20/26 | 31.23 on 11/21/25 | 28.66 on 02/19/26 | ||
| High | 42.00 on 11/26/25 | 38.00 on 12/08/25 | 89.00 on 12/15/25 | ||
| 6-Month | |||||
| %Chg | +42.27% since 08/20/25 | +41.82% since 08/20/25 | -53.05% since 08/20/25 | ||
| Low | 23.05 on 09/15/25 | 22.22 on 09/18/25 | 28.66 on 02/19/26 | ||
| High | 42.00 on 11/26/25 | 38.00 on 12/08/25 | 91.00 on 10/08/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 3,926,730 | 4,305,688 | 3,601,638 | ||
| Shares Outstanding, K | 113,391 | 125,020 | 105,188 | ||
| Annual Sales | 45,560,000 | 1,188,000,000 | 675,040,000 | ||
| Annual Net Income | -241,600,000 | 2,000,000 | 141,210,000 | ||
| Last Quarter Sales | 350,000 | 314,000,000 | 207,640,000 | ||
| Last Quarter Net Income | -72,010,000 | 42,000,000 | 19,670,000 | ||
| 60-Month Beta | 0.06 | 0.80 | 0.25 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.41 on 11/05/25 | 0.72 on 10/30/25 | 0.16 on 11/04/25 | ||
| Latest Earnings Date | 05/14/26 | 02/26/26 | 02/24/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 17.53 | 45.25 | ||